Skip to content

Clinical trials

Phase 3 Insulin Resistance trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 3 Clear all

137 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20032
20043
20055
20068
20074
20085
200910
20107
201113
20126
20137
20147
20153
20165
20174
20182
20199
20202
20213
20224
20233
20243
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95
Unknown status18
Terminated7
Withdrawn5
Recruiting4
Not yet recruiting4
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanabe Pharma Corporation5
Geropharm4
Population Health Research Institute4
Ain Shams University3
Gan & Lee Pharmaceuticals.3
Gan and Lee Pharmaceuticals, USA3
Sanofi3
Sanwa Kagaku Kenkyusho Co., Ltd.3
AstraZeneca2
Biodel2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance137
Diabetes Mellitus, Type 240
Diabetes Mellitus39
Obesity20
Diabetes Mellitus, Type 116
Polycystic Ovary Syndrome8
Cardiovascular Diseases7
Hyperglycemia7
Metabolic Syndrome7
Weight Loss7

Trials

Showing 26 to 50 of 137. Each trial links to its page on Pharma Observatory.

37 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.